 |
|
|
| |
Non-Inferior Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) vs DTG Plus Tenofovir/Emtricitabine (TDF/FTC) Fixed-Dose Combination in Antiretroviral Treatment-Naive Adults With HIV-1 Infection-Week 48 Results From the GEMINI Studies
|
| |
| |
Reported by Jules Levin
22nd International AIDS Conference; July 23-27, 2018; Amsterdam, the Netherlands
P. Cahn,1J. Sierra Madero,2J. Arribas,3A. Antinori,4R. Ortiz,5A. Clarke,6C.-C. Hung,7J. Rockstroh,8P.-M. Girard,9C. Man,10J. Sievers,11A. Currie,12M. Underwood,10A. Tenorio,10K. Pappa,10B. Wynne,10M. Gartland,10M. Aboud,11K. Smith10
1Fundacion Huesped, Buenos Aires, Argentina; 2Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico; 3Hospital La Paz, Madrid, Spain; 4Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Rome, Italy; 5Bliss Healthcare Services, Orlando, FL, USA; 6Royal Sussex County Hospital, Brighton, UK; 7National Taiwan University Hospital, Taipei, Taiwan, Province of China; 8Rheinische Friedrich-Wilhelms Universitat, Bonn, Germany; 9Hopital Saint Antoine, Paris, France; 10ViiV Healthcare, Research Triangle Park, NC, USA;
11ViiV Healthcare, Brentford, UK; 12GlaxoSmithKline, Stockley Park, UK
|
| |
|
|
|
|
|
